All Posts By

The Fenway Institute

Take Action To Defend Health Care For Vulnerable Populations!

By | Fenway Health Newsroom, Health Care, Health Policy, HIV/AIDS, LGBT Health, News, The Fenway Institute, Women's Health | No Comments
The United States Senate is currently working on its proposal to repeal and replace the Affordable Care Act (ACA), which ensured coverage of essential health benefits, protected patients with preexisting conditions, and expanded Medicaid eligibility. This resulted in increased access to health care for everyone, but it especially benefited vulnerable populations that were less likely to have health insurance, including LGBT people, people with HIV, and Black and Latino people. Passage of the American Health Care Act (AHCA) would jeopardize the gains made under the ACA by: Cutting healthcare for 23 million Americans, according to the Congressional Budget Office (CBO). 
Read More

Fenway Health Announces Appointment of Dr. Jennifer Potter as Co-Chair of The Fenway Institute

By | Fenway Health Newsroom, Fenway News, LGBT Health, News, The Fenway Institute | One Comment
Fenway Health announces today that Dr. Jennifer Potter has been appointed Co-Chair of The Fenway Institute. Dr. Potter is Director of Women’s Health at Fenway as well as an Advisory Dean and Director of the William B. Castle Society at Harvard Medical School. She has directed Women’s Health Research at The Fenway Institute since 2015, and has been a member of the faculty since 2010. She is a physician at Beth Israel Deaconess Medical Center and Fenway Health. Dr. Potter will join Dr. Kenneth H. Mayer, who has been a Co-Chair of The Fenway Institute since 2001, in leading The 
Read More

People with HIV, LGBT people, and Black and Latino people would disproportionately lose health insurance under the American Health Care Act

By | Health Care, Health Policy, HIV/AIDS, HIV/AIDS, LGBT Health, The Fenway Institute | No Comments
On May 24, the Congressional Budget Office (CBO) projected that the amended American Health Care Act (AHCA), which narrowly passed the U.S. House on May 4, would result in 23 million Americans losing their health insurance by 2026 as compared with what would be expected under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). “It is clear from the CBO analysis that the amended Republican health care plan is no better than the original bill,” said Sean Cahill, Director of Health Policy Research at The Fenway Institute. “Of the 23 million Americans projected to lose their 
Read More

Study Explores Less Invasive Options For Transmasculine Sexual Health Screening

By | Education, Fenway Health Newsroom, Health Care, LGBT Health, Research, The Fenway Institute, Trans | No Comments
Female-to-male (FTM) transgender men and transmasculine individuals are people who are assigned female at birth but identify as male or as masculine. Many FTM transgender men and transmasculine individuals are born with reproductive organs typically labeled as female (e.g. cervix), and most FTM transgender men and transmasculine individuals do not choose to undergo a full hysterectomy (removal of the uterus, cervix, fallopian tubes, and ovaries).1 Because of this, many FTM and transmasculine people are at risk for cervical cancer, human papillomavirus (HPV), as well as other sexually transmitted infections (STIs) and may not realize it. It is recommended that anybody 
Read More

Volunteers Needed For New PrEP Study That Could Revolutionize HIV Prevention

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
Increased public awareness and use of pre-exposure prophylaxis (PrEP) has been tremendously powerful in the global battle against HIV/AIDS. Studies have shown that, when taken as a daily pill, PrEP is 92-99% effective at preventing HIV infections in HIV-negative individuals. However, as with any daily medication, strict adherence is the key to success – and, for many people, this may become a barrier to PrEP’s effectiveness. The Fenway Institute is serving as a site for a new study, HPTN 083, that explores whether injectable, long-acting PrEP, is a viable alternative to oral PrEP. Injectable PrEP has the potential to truly 
Read More